As of Aug 28
| +0.01 / +0.14%|
The 4 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 19.00 and a low estimate of 11.00. The median estimate represents a +55.62% increase from the last price of 7.39.
The current consensus among 4 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.